Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients (Q30970793)

12 August 2017

Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients (English)

1 reference

12 August 2017

3

Annapurna Poduri

1 reference

12 August 2017

1

Florence T Bourgeois

1 reference

12 August 2017

4

Kenneth D Mandl

1 reference

12 August 2017

Karen L Olson

2

1 reference

12 August 2017

13 June 2015

1 reference

12 August 2017

1 reference

12 August 2017

17

1 reference

12 August 2017

5

1 reference

12 August 2017

401-410

1 reference

Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Pediatric versus adult drug trials for conditions with high pediatric disease burden

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Quality of reporting of neonatal and infant trials in high-impact journals

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Observational studies in systematic [corrected] reviews of comparative effectiveness: AHRQ and the Effective Health Care Program.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994-2007.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Observational Methods in Comparative Effectiveness Research

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

A descriptive analysis of a representative sample of pediatric randomized controlled trials published in 2007.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Geographic variation in the quality of prescribing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published 1948-2006.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Designing comparative effectiveness research on prescription drugs: lessons from the clinical trial literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

RCTs with new antiepileptic drugs in children: a systematic review of monotherapy studies and their methodology.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Measuring outcomes of treatment with antiepileptic drugs in clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Market variations in intensity of Medicare service use and beneficiary experiences with care

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Child vs adult randomized controlled trials in specialist journals: a citation analysis of trends, 1985-2005.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Prescription refill records as a screening tool to identify antidepressant non-adherence.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Comparison of various measures for assessing medication refill adherence using prescription data.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Child versus adult research: the gap in high-quality study design

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Gap in publication of comparative information on new medicines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Off-label and unlicensed prescribing for children: have we made any progress?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

An absence of pediatric randomized controlled trials in general medical journals, 1985-2004.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

A simple and valid tool distinguished efficacy from effectiveness studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Methods for evaluation of medication adherence and persistence using automated databases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

New, but not improved? Incorporating comparative-effectiveness information into FDA labeling

21 June 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

Antiepileptic drugs in Australia: 2002-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

Comparison of measures of medication persistency using a prescription drug database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

New antiepileptic drugs in practice--how do they perform in the real world?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

The impact of side effects on long-term retention in three new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

The Role and Impact of Research Agendas on the Comparative-Effectiveness Research Among Antihyperlipidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40272-015-0139-Z

A randomised open trial comparing monotherapy with topiramate versus carbamazepine in the treatment of paediatric patients with recently diagnosed epilepsy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4573831

Building Comparative Efficacy and Tolerability Into the FDA Approval Process

25 November 2018

1 reference

12 December 2020

Why Observational Studies Should Be Among The Tools Used In Comparative Effectiveness Research

1 reference

12 December 2020

Evidence of comparative efficacy should have a formal role in European drug approvals

1 reference

12 December 2020

Comparative-Effectiveness Research as It Affects Clinical Pharmacology

1 reference

12 December 2020

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

1 reference

12 December 2020

Comparative retention rates and long-term tolerability of new antiepileptic drugs

1 reference

12 December 2020

Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy

1 reference

12 December 2020

10.1007/S40272-015-0139-Z

Identifiers

DOI

1 reference

PMC publication ID

4573831

Dimensions Publication ID

12 August 2017

0 references

1 reference

PMC publication ID

4573831

12 August 2017

PubMed publication ID

26070280

1 reference

PMC publication ID

4573831